RelB: An outlier in leukocyte biology

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 941-951

  Millet, Patrick ^a   Mccall, Charles ^a   Yoza, Barbra ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Bioenergy; Endotoxin tolerance; Inflammation; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; XENOBIOTIC AGENT;

ADAPTIVE IMMUNITY; APOPTOSIS; BIOENERGY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CHROMATIN STRUCTURE; CIRCADIAN RHYTHM; DEATH; DNA SEQUENCE; GENE EXPRESSION; GENE PRODUCT; GENE STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; XENOBIOTIC METABOLISM;

BIOENERGY; ENDOTOXIN TOLERANCE; INFLAMMATION; NF-ΚB;

CIRCADIAN RHYTHM; HUMANS; LEUKOCYTES; NF-KAPPA B; PROTEIN STABILITY; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTION FACTOR RELB;

EID: 84885451922     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0513305     Document Type: Review

References (122)

1. Hayden, M. S. (2012) A less-canonical, canonical NF-κB pathway in DCs. Nat. Immunol. 13, 1139-1141.
2. Vallabhapurapu, S., Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
3. McCall, C. E., Yoza, B. K. (2007) Gene silencing in severe systemic inflammation. Am. J. Respir. Crit. Care Med. 175, 763-767.
4. Yoza, B. K., Hu, J. Y., Cousart, S. L., Forrest, L. M., McCall, C. E. (2006) Induction of RelB participates in endotoxin tolerance. J. Immunol. 177, 4080-4085.
5. Liu, T. F., Yoza, B. K., El Gazzar, M., Vachharajani, V. T., McCall, C. E. (2011) NAD-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286, 9856-9864.
6. Moorthy, A. K., Huang, D. B., Wang, V. Y., Vu, D., Ghosh, G. (2007) X-Ray structure of a NF-κB p50/RelB/DNA complex reveals assembly of multiple dimers on tandem B sites. J. Mol. Biol. 373, 723-734.
7. Vogel, C. F., Sciullo, E., Li, W., Wong, P., Lazennec, G., Matsumura, F. (2007) RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 21, 2941-2955.
8. Bellet, M. M., Zocchi, L., Sassone-Corsi, P. (2012) The RelB subunit of NF B acts as a negative regulator of circadian gene expression. Cell Cycle 11, 3304-3311.
9. Ryseck, R. P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., Bravo, R. (1992) RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12, 674-684.
10. Ruben, S. M., Klement, J. F., Coleman, T. A., Maher, M., Chen, C. H., Rosen, C. A. (1992) I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev. 6, 745-760.
11. Bours, V., Azarenko, V., Dejardin, E., Siebenlist, U. (1994) Human RelB (I-Rel) functions as a B site-dependent transactivating member of the family of Rel-related proteins. Oncogene 9, 1699-1702.
12. Baldwin A. S., Jr., (1996) The NF-κB and I B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
13. Alber, T. (1992) Structure of the leucine zipper. Curr. Opin. Genet. Dev. 2, 205-210.
14. Dobrzanski, P., Ryseck, R. P., Bravo, R. (1993) Both N-and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13, 1572-1582.
15. Chen, F. (2002, Jan.) RELB (v-rel reticuloendotheliosis viral oncogene homolog B). Atlas Genet. Cytogenet. Oncol. Haematol. Retrieved from http://AtlasGeneticsOncology.org/Genes/RELBID324.html.
16. ENCODE Project Consortium, Dunham, I., Kundaje, A., Aldred, S. F., Collins, P. J., Davis, C. A., Doyle, F., Epstein, C. B., Frietze, S., Harrow, J., et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74.
17. Ammon, C., Mondal, K., Andreesen, R., Krause, S. W. (2000) Differential expression of the transcription factor NF-κB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Biochem. Biophys. Res. Commun. 268, 99-105.
18. Carrasco, D., Ryseck, R. P., Bravo, R. (1993) Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118, 1221-1231.
19. Bren, G. D., Solan, N. J., Miyoshi, H., Pennington, K. N., Pobst, L. J., Paya, C. V. (2001) Transcription of the RelB gene is regulated by NF-κB. Oncogene 20, 7722-7733.
20. Mineva, N. D., Rothstein, T. L., Meyers, J. A., Lerner, A., Sonenshein, G. E. (2007) CD40 ligand-mediated activation of the de novo RelB NF-κB synthesis pathway in transformed B cells promotes rescue from apoptosis. J. Biol. Chem. 282, 17475-17485.
21. Wang, X., Sonenshein, G. E. (2005) Induction of the RelB NF-κB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J. Virol. 79, 95-105.
22. Dong, X., Craig, T., Xing, N., Bachman, L. A., Paya, C. V., Weih, F., McKean, D. J., Kumar, R., Griffin, M. D. (2003) Direct transcriptional regulation of RelB by 1,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278, 49378-49385.
23. Li, T., Morgan, M. J., Choksi, S., Zhang, Y., Kim, Y. S., Liu, Z. G. (2010) MicroRNAs modulate the noncanonical transcription factor NF-κB pathway by regulating expression of the kinase IKK during macrophage differentiation. Nat. Immunol. 11, 799-805
24. Etzrodt, M., Cortez-Retamozo, V., Newton, A., Zhao, J., Ng, A., Wildgruber, M., Romero, P., Wurdinger, T., Xavier, R., Geissmann, F., Meylan, E., Nahrendorf, M., Swirski, F. K., Baltimore, D., Weissleder, R., Pittet, M. J. (2012) Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep. 1, 317-324.
25. Ley, K., Miller, Y. I., Hedrick, C. C. (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31, 1506-1516.
26. Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., Baltimore, D. (2011) NF-κB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108, 9184-9189.
27. El Gazzar, M., Church, A., Liu, T., McCall, C. E. (2011) MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-during TLR4-induced gene reprogramming. J. Leukoc. Biol. 90, 509-519.
28. Marienfeld, R., Berberich-Siebelt, F., Berberich, I., Denk, A., Serfling, E., Neumann, M. (2001) Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control. Oncogene 20, 8142-8147.
29. Maier, H. J., Marienfeld, R., Wirth, T., Baumann B. (2003) Critical role of RelB serine 368 for dimerization and p100 stabilization J. Biol. Chem. 78, 39242-39250.
30. Fusco, A. J., Savinova, O. V., Talwar, R., Kearns, J. D., Hoffmann, A., Ghosh, G. (2008) Stabilization of RelB requires multidomain interactions with p100/p52. J. Biol. Chem. 283, 12324-12332.
31. Xiao, G., Harhaj, E. W., Sun, S. C. (2001) NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401-409.
32. Heusch, M., Lin, L., Geleziunas, R., Greene, W. C. (1999) The generation of NF-κB2 p52: mechanism and efficiency. Oncogene 18, 6201-6208.
33. Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D., Paya, C. V. (2002) RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277, 1405-1418.
34. Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M., Hoffmann, A. (2007) A fourth I B protein within the NF-κB signaling module. Cell 128, 369-381.
35. Shih, V. F., Tsui, R., Caldwell, A., Hoffmann, A. (2011) A single NF B system for both canonical and non-canonical signaling. Cell Res. 21, 86-102.
36. Wietek, C., O'Neill, L. A. (2007) Diversity and regulation in the NF-κB system. Trends Biochem. Sci. 32, 311-319.
37. Beinke, S., Ley, S. C. (2004) Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem. J. 382, 393-409.
38. Neumann, M., Klar, S., Wilisch-Neumann, A., Hollenbach, E., Kavuri, S., Leverkus, M., Kandolf, R., Brunner-Weinzierl, M. C., Klingel, K. (2011) Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation. Oncogene 30, 2485-2492.
39. Shih, V. F., Davis-Turak, J., Macal, M., Huang, J. Q., Ponomarenko, J., Kearns, J. D., Yu, T., Fagerlund, R., Asagiri, M., Zuniga, E. I., Hoffmann, A. (2012) Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Nat. Immunol. 13, 1162-1170.
40. Müller, J. R., Siebenlist, U. (2003) Lymphotoxin β receptor induces sequential activation of distinct NF-κB factors via separate signaling pathways. J. Biol. Chem. 278, 12006-12012.
41. Derudder, E., Dejardin, E., Pritchard, L. L., Green, D. R., Korner, M., Baud, V. (2003) RelB/p50 dimers are differentially regulated by tumor necrosis factor-and lymphotoxin-β receptor activation: critical roles for p100. J. Biol. Chem. 278, 23278-23284.
42. Liao, G., Zhang, M., Harhaj, E. W., Sun, S. C. (2004) Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250.
43. Sun, S. C. (2011) Non-canonical NF-κB signaling pathway. Cell Res. 21, 71-85.
44. Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W. C., Mak, T. W., Korneluk, R. G., Cheng, G. (2008) Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378.
45. Xiao, G., Fong, A., Sun, S. C. (2004) Induction of p100 processing by NF-κB-inducing kinase involves docking I B kinase (IKK) to p100 and IKK-mediated phosphorylation. J. Biol. Chem. 279, 30099-30105.
46. Liang, C., Zhang, M., Sun, S. C. (2006) β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870. Cell. Signal. 18, 1309-1317.
47. He, J. Q., Zarnegar, B., Oganesyan, G., Saha, S. K., Yamazaki, S., Doyle, S. E., Dempsey, P. W., Cheng, G. (2006) Rescue of TRAF3-null mice by p100 NF-κB deficiency. J. Exp. Med. 203, 2413-2418.
48. Yilmaz, Z. B., Weih, D. S., Sivakumar, V., Weih, F. (2003) RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22, 121-130.
49. Weih, D. S., Yilmaz, Z. B., Weih, F. (2001) Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167, 1909-1919.
50. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A., Bravo, R. (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80, 331-340.
51. Gerondakis, S., Grumont, R., Gugasyan, R., Wong, L., Isomura, I., Ho, W., Banerjee, A. (2006) Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781-6799.
52. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., Lo, D. (1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536.
53. Weih, F., Durham, S. K., Barton, D. S., Sha, W. C., Baltimore, D., Bravo, R. (1997) p50-NF-κB complexes partially compensate for the absence of RelB: severely increased pathology in p50(/)relB(/) double-knockout mice. J. Exp. Med. 185, 1359-1370.
54. Naspetti, M., Aurrand-Lions, M., DeKoning, J., Malissen, M., Galland, F., Lo, D., Naquet, P. (1997) Thymocytes and RelB-dependent medullary epithelial cells provide growth-promoting and organization signals, respectively, to thymic medullary stromal cells. Eur. J. Immunol. 27, 1392-1397.
55. Barton, D., HogenEsch, H., Weih, F. (2000) Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 30, 2323-2332.
56. DeKoning, J., DiMolfetto, L., Reilly, C., Wei, Q., Havran, W. L., Lo, D. (1997) Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J. Immunol. 158, 2558-2566.
57. Caamaño, J., Alexander, J., Craig, L., Bravo, R., Hunter, C. A. (1999) The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163, 4453-4461.
58. Ishimaru, N., Kishimoto, H., Hayashi, Y., Sprent, J. (2006) Regulation of naive T cell function by the NF-κB2 pathway. Nat. Immunol. 7, 763-772.
59. Matsumoto, M., Yamada, T., Yoshinaga, S. K., Boone, T., Horan, T., Fujita, S., Li, Y., Mitani, T. (2002) Essential role of NF-κB-inducing kinase in T cell activation through the TCR/CD3 pathway. J. Immunol. 169, 1151-1158.
60. Attar, R. M., Caamaño, J., Carrasco, D., Iotsova, V., Ishikawa, H., Ryseck, R. P., Weih, F., Bravo, R. (1997) Genetic approaches to study Rel/NF-κB/I B function in mice. Semin. Cancer Biol. 8, 93-101.
61. Kosco-Vilbois, M. H., Bonnefoy, J. Y., Chvatchko, Y. (1997) The physiology of murine germinal center reactions. Immunol. Rev. 156, 127-136.
62. Gardam, S., Sierro, F., Basten, A., Mackay, F., Brink, R. (2008) TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391-401.
63. Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., Brink, R. (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20, 785-798.
64. Tan, J. K., Ni, K., Le, F., O'Neill, H. C. (2007) Hematopoiesis of immature myeloid dendritic cells in stroma-dependent spleen long-term cultures occurs independently of NF-κB/RelB function. Exp. Hematol. 35, 1580-1593.
65. Zhao, C., Xiu, Y., Ashton, J., Xing, L., Morita, Y., Jordan, C. T., Boyce, B. F. (2012) Noncanonical NF-κB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions. Stem Cells 30, 709-718.
66. Tully, J. E., Nolin, J. D., Guala, A. S., Hoffman, S. M., Roberson, E. C., Lahue, K. G., van der Velden, J., Anathy, V., Blackwell, T. S., Janssen-Heininger, Y. M. (2012) Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells. Am. J. Respir. Cell. Mol. Biol. 47, 497-508.
67. Baglole, C. J., Maggirwar, S. B., Gasiewicz, T. A., Thatcher, T. H., Phipps, R. P., Sime, P. J. (2008) The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-κB family member RelB. J. Biol. Chem. 283, 28944-28957.
68. Benedetti, G., Fokkelman, M., Yan, K., Fredriksson, L., Herpers, B., Meerman, J., van de Water, B., de Graauw, M. (2013) The nuclear factor B family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin/tumor necrosis factor synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch. Mol. Pharmacol. 84, 128-138.
69. Canicio, J., Ruiz-Lozano, P., Carrasco, M., Palacin, M., Chien, K., Zorzano, A., Kaliman, P. (2001) Nuclear factor B-inducing kinase and I B kinasesignal skeletal muscle cell differentiation. J. Biol. Chem. 276, 20228-20233.
70. Charan, R. A., Hanson, R., Clemens, P. R. (2012) Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice. FASEB J. 26, 587-595.
71. Bakkar, N., Wang, J., Ladner, K. J., Wang, H., Dahlman, J. M., Carathers, M., Acharyya, S., Rudnicki, M. A., Hollenbach, A. D., Guttridge, D. C. (2008) IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180, 787-802.
72. Eisner, V., Quiroga, C., Criollo, A., Eltit, J. M., Chiong, M., Parra, V., Hidalgo, K., Toro, B., Díaz-Araya, G., Lavandero, S. (2006) Hyperosmotic stress activates p65/RelB NF B in cultured cardiomyocytes with dichotomic actions on caspase activation and cell death. FEBS Lett. 580, 3469-3476.
73. Bakkar, N., Ladner, K., Canan, B. D., Liyanarachchi, S., Bal, N. C., Pant, M., Periasamy, M., Li, Q., Janssen, P. M., Guttridge, D. C. (2012) IKK and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 196, 497-511.
74. Baud, V., Jacque, E. (2008) The alternative NF-κB activation pathway and cancer: friend or foe? Med. Sci. (Paris) 24, 1083-1088.
75. Josson, S., Xu, Y., Fang, F., Dhar, S. K., St Clair, D. K., St Clair, W. H. (2006) RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene 25, 1554-1559.
76. Demicco, E. G., Kavanagh, K. T., Romieu-Mourez, R., Wang, X., Shin, S. R., Landesman-Bollag, E., Seldin, D. C., Sonenshein, G. E. (2005) RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor I B-expression and promote carcinogenesis of the mammary gland. Mol. Cell. Biol. 25, 10136-10147.
77. Wang, X., Belguise, K., Kersual, N., Kirsch, K. H., Mineva, N. D., Galtier, F., Chalbos, D., Sonenshein, G. E. (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9, 470-478.
78. Bohrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Mannel, D., Bottiger, B. W., Stern, D. M., Waldherr, R., Saeger, H. D., Ziegler, R., Bierhaus, A., Martin, E., Nawroth, P. P. (1997) Role of NF B in the mortality of sepsis. J. Clin. Invest. 100, 972-985.
79. Wang, H., Ma, S. (2008) The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am. J. Emerg. Med. 26, 711-715.
80. McCall, C. E., Yoza, B., Liu, T., El Gazzar, M. (2010) Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2, 395-405.
81. Beeson, P. (1947) Tolerance to bacterial pyrogens. J. Exp. Med. 86, 29-41.
82. Granowitz, E. V., Porat, R., Mier, J. W., Orencole, S. F., Kaplanski, G., Lynch, E. A., Ye, K., Vannier, E., Wolff, S. M., Dinarello, C. A. (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151, 1637-1645.
83. Biswas, S. K., Lopez-Collazo, E. (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487.
84. Sanchez-Cantu, L., Rode, H. N., Christou, N. V. (1989) Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch. Surg. 124, 1432-1436.
85. Cavaillon, J. M., Adib-Conquy, M. (2005) Monocytes/macrophages and sepsis. Crit. Care Med. 33, S506-S509.
86. McCall, C. E., Grosso-Wilmoth, L. M., LaRue, K., Guzman, R. N., Cousart, S. L. (1993) Tolerance to endotoxin-induced expression of the interleukin-1 β gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91, 853-861.
87. Souza-Fonseca-Guimaraes, F., Adib-Conquy, M., Cavaillon, J. M. (2012) Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol. Med. 18, 270-285.
88. Matsushita, H., Ohta, S., Shiraishi, H., Suzuki, S., Arima, K., Toda, S., Tanaka, H., Nagai, H., Kimoto, M., Inokuchi, A., Izuhara, K. (2010) Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells. Int. Immunol. 22, 739-747.
89. Yoza, B. K., Hu, J. Y., Cousart, S. L., McCall, C. E. (2000) Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock 13, 236-243.
90. Xia, Y., Pauza, M. E., Feng, L., Lo, D. (1997) RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol. 151, 375-387.
91. Marienfeld, R., May, M. J., Berberich, I., Serfling, E., Ghosh, S., Neumann, M. (2003) RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278, 19852-19860.
92. LaRue, K. E., McCall, C. E. (1994) A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180, 2269-2275.
93. Madge, L. A., May, M. J. (2011) The NF B paradox: RelB induces and inhibits gene expression. Cell Cycle 10, 6-7.
94. Chan, C., Li, L., McCall, C. E., Yoza, B. K. (2005) Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1promoter. J. Immunol. 175, 461-468.
95. Yoza, B. K., McCall, C. E. (2011) Facultative heterochromatin formation at the IL-1 β promoter in LPS tolerance and sepsis. Cytokine 53, 145-152.
96. Jacque, E., Tchenio, T., Piton, G., Romeo, P. H., Baud, V. (2005) RelA repression of RelB activity induces selective gene activation down-stream of TNF receptors. Proc. Natl. Acad. Sci. USA 102, 14635-14640.
97. Saccani, S., Pantano, S., Natoli, G. (2003) Modulation of NF-κB activity by exchange of dimers. Mol. Cell. 11, 1563-1574.
98. McCall, C. E., El Gazzar, M., Liu, T., Vachharajani, V., Yoza, B. (2011) Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90, 439-446.
99. Chen, X., El Gazzar, M., Yoza, B. K., McCall, C. E. (2009) The NF-κB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J. Biol. Chem. 284, 27857-27865.
100. El Gazzar, M., Liu, T., Yoza, B. K., McCall, C. E. (2010) Dynamic and selective nucleosome repositioning during endotoxin tolerance. J. Biol. Chem. 285, 1259-1271.
101. Tando, T., Ishizaka, A., Watanabe, H., Ito, T., Iida, S., Haraguchi, T., Mizutani, T., Izumi, T., Isobe, T., Akiyama, T., Inoue, J., Iba, H. (2010) Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-κB pathway. J. Biol. Chem. 285, 21951-21960.
102. Wilson, B. G., Roberts, C. W. (2011) SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 11, 481-492.
103. Kayama, H., Ramirez-Carrozzi, V. R., Yamamoto, M., Mizutani, T., Kuwata, H., Iba, H., Matsumoto, M., Honda, K., Smale, S. T., Takeda, K. (2008) Class-specific regulation of pro-inflammatory genes by MyD88 pathways and I B. J. Biol. Chem. 283, 12468-12477.
104. Milne, J. C., Denu, J. M. (2008) The sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12, 11-17.
105. Liu, T. F., Vachharajani, V. T., Yoza, B. K., McCall, C. E. (2012) NAD-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J. Biol. Chem. 287, 25758-25769.
106. Hart, D. W., Gore, D. C., Rinehart, A. J., Asimakis, G. K., Chinkes, D. L. (2003) Sepsis-induced failure of hepatic energy metabolism. J. Surg. Res. 115, 139-147.
107. Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., Spiegelman, B. M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
108. Stasik, I., Rapak, A., Zioło, E., Strzadała, L. (2008) The mitochondrial localization of RelB and NFATx in immature T cells. Cell. Mol. Biol. Lett. 13, 493-501.
109. Cogswell, P. C., Kashatus, D. F., Keifer, J. A., Guttridge, D. C., Reuther, J. Y., Bristow, C., Roy, S., Nicholson, D. W., Baldwin A. S., Jr., (2003) NF-κB and I B are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-κB. J. Biol. Chem. 278, 2963-2968.
110. Johnson, R. F., Witzel, I. I., Perkins, N. D. (2011) p53-Dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB. Cancer Res. 71, 5588-5597.
111. Giralt, A., Villarroya, F. (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem. J. 444, 1-10.
112. Gonzalez, F. J., Fernandez-Salguero, P. (1998) The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Dispos. 26, 1194-1198.
113. McMillan, D. H., Baglole, C. J., Thatcher, T. H., Maggirwar, S., Sime, P. J., Phipps, R. P. (2011) Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation. Am. J. Pathol. 179, 125-133.
114. Vogel, C. F., Matsumura, F. (2009) A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family. Biochem. Pharmacol. 77, 734-745.
115. Huang, W., Ramsey, K. M., Marcheva, B., Bass, J. (2011) Circadian rhythms, sleep, and metabolism. J. Clin. Invest. 121, 2133-2141
116. Imai, S. (2009) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr. Pharm. Des. 15, 20-28.
117. Shimba, S., Watabe, Y. (2009) Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem. Pharmacol. 77, 560-565.
118. Cavadini, G., Petrzilka, S., Kohler, P., Jud, C., Tobler, I., Birchler, T., Fontana, A. (2007) TNF-suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. USA 104, 12843-12848.
119. Hashiramoto, A., Yamane, T., Tsumiyama, K., Yoshida, K., Komai, K., Yamada, H., Yamazaki, F., Doi, M., Okamura, H., Shiozawa, S. (2010) Mammalian clock gene cryptochrome regulates arthritis via proinflammatory cytokine TNF. J. Immunol. 184, 1560-1565.
120. Narasimamurthy, R., Hatori, M., Nayak, S. K., Liu, F., Panda, S., Verma, I. M. (2012) Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc. Natl. Acad. Sci. USA 109, 12662-12667.
121. Haimovich, B., Calvano, J., Haimovich, A. D., Calvano, S. E., Coyle, S. M., Lowry, S. F. (2010) In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes. Crit. Care Med. 38, 751-758.
122. Verceles, A. C., Silhan, L., Terrin, M., Netzer, G., Shanholtz, C., Scharf, S. M. (2012) Circadian rhythm disruption in severe sepsis: the effect of ambient light on urinary 6-sulfatoxymelatonin secretion. Intensive Care Med. 38, 804-810.